HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Domenico Ribatti Selected Research

Monoclonal Antibodies

10/2022Immunosuppressive effects of vascular endothelial growth factor.
8/2018VEGFA and VEGFR2 RNAscope determination in gastric cancer.
3/2016Targeting B-cell non Hodgkin lymphoma: New and old tricks.
9/2014From the discovery of monoclonal antibodies to their therapeutic application: an historical reappraisal.
2/2008Increase of therapeutic effects by treating melanoma with targeted combinations of c-myc antisense and doxorubicin.
1/2008Napoleone Ferrara and the saga of vascular endothelial growth factor.
5/2007Tryptase- and leptin-positive mast cells correlate with vascular density in uterine leiomyomas.
5/2007Neovascularization and mast cells with tryptase activity increase simultaneously in human pterygium.
1/2006Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: from the biology to the clinic.
12/2005Neovascularization and mast cells with tryptase activity increase simultaneously with pathologic progression in human endometrial cancer.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Domenico Ribatti Research Topics

Disease

186Neoplasms (Cancer)
01/2024 - 02/2002
39Multiple Myeloma
01/2021 - 04/2002
23Neuroblastoma
11/2022 - 07/2003
18Melanoma (Melanoma, Malignant)
01/2022 - 09/2002
17Inflammation (Inflammations)
01/2021 - 07/2003
15Hypoxia (Hypoxemia)
07/2016 - 09/2002
11Neoplasm Metastasis (Metastasis)
01/2023 - 10/2003
11Breast Neoplasms (Breast Cancer)
12/2021 - 07/2009
9B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
03/2016 - 08/2003
8Lymphoma (Lymphomas)
07/2022 - 08/2008
7Fibrosis (Cirrhosis)
12/2021 - 08/2015
7Necrosis
02/2017 - 04/2002
6Monoclonal Gammopathy of Undetermined Significance
01/2021 - 09/2009
6Disease Progression
01/2021 - 07/2004
6Adenocarcinoma
11/2017 - 12/2005
6Carcinoma (Carcinomatosis)
03/2013 - 05/2005
5Renal Cell Carcinoma (Grawitz Tumor)
03/2023 - 12/2014
5Glioblastoma (Glioblastoma Multiforme)
12/2022 - 12/2009
5Wounds and Injuries (Trauma)
01/2021 - 05/2007
5Pterygium
01/2018 - 05/2007
5Pathologic Neovascularization
01/2017 - 01/2008
5Anemia
11/2014 - 11/2002
5Paraproteinemias (Monoclonal Gammopathy)
02/2014 - 02/2003
4Carcinogenesis
12/2021 - 09/2008
4Autoimmune Diseases (Autoimmune Disease)
12/2021 - 02/2013
4Glioma (Gliomas)
10/2014 - 06/2010
3Meningioma (Meningiomas)
12/2022 - 12/2011
3Brain Neoplasms (Brain Tumor)
12/2022 - 10/2011
3Ovarian Neoplasms (Ovarian Cancer)
10/2022 - 05/2005
3Neurodegenerative Diseases (Neurodegenerative Disease)
01/2022 - 04/2014
3Non-Hodgkin Lymphoma (Lymphosarcoma)
03/2020 - 08/2005
3Retinal Neovascularization
01/2020 - 07/2013
3Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
10/2019 - 05/2003
3Pancreatic Neoplasms (Pancreatic Cancer)
03/2019 - 12/2011
3Stomach Neoplasms (Stomach Cancer)
08/2018 - 08/2010
3Endometrial Neoplasms (Endometrial Cancer)
02/2017 - 12/2005
3Colorectal Neoplasms (Colorectal Cancer)
01/2016 - 10/2004
3Globoid Cell Leukodystrophy (Krabbe Disease)
10/2015 - 09/2013

Drug/Important Bio-Agent (IBA)

59Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2023 - 09/2002
34CytokinesIBA
11/2022 - 02/2003
20Tryptases (Tryptase)IBA
03/2021 - 08/2003
17Proteins (Proteins, Gene)FDA Link
01/2021 - 08/2002
15Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
09/2019 - 12/2004
12Angiogenesis InhibitorsIBA
10/2020 - 02/2003
11Monoclonal AntibodiesIBA
10/2022 - 10/2003
10Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2019 - 02/2002
9ErythropoietinFDA Link
01/2019 - 05/2007
9Bortezomib (Velcade)FDA Link
03/2018 - 01/2006
8Biomarkers (Surrogate Marker)IBA
01/2022 - 08/2008
8AntibodiesIBA
10/2021 - 12/2009
8LigandsIBA
01/2020 - 10/2006
8Peptides (Polypeptides)IBA
11/2018 - 11/2003
7ChemokinesIBA
12/2023 - 02/2003
7Liposomes (Liposome)IBA
11/2018 - 10/2003
6Bevacizumab (Avastin)FDA Link
10/2022 - 01/2006
6Doxorubicin (Adriamycin)FDA LinkGeneric
11/2018 - 10/2006
6Matrix Metalloproteinases (MMPs)IBA
09/2015 - 12/2004
6Therapeutic UsesIBA
03/2015 - 07/2007
5Oxygen (Dioxygen)IBA
01/2022 - 07/2008
5Messenger RNA (mRNA)IBA
01/2022 - 09/2002
5Protein Isoforms (Isoforms)IBA
10/2019 - 12/2004
5CD13 Antigens (Alanine Aminopeptidase)IBA
09/2013 - 11/2003
5Interleukin-12 (IL 12)IBA
11/2011 - 03/2007
5Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
01/2008 - 12/2004
4Peptide Hydrolases (Proteases)FDA Link
05/2024 - 02/2002
4PTX3 proteinIBA
11/2023 - 01/2013
4Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
01/2023 - 02/2017
4AntigensIBA
01/2022 - 11/2003
4RNA (Ribonucleic Acid)IBA
01/2022 - 07/2008
4Transforming Growth Factors (Transforming Growth Factor)IBA
03/2021 - 06/2017
4EnzymesIBA
11/2020 - 08/2002
4GalactosylceramidaseIBA
11/2020 - 09/2013
4Interleukin-6 (Interleukin 6)IBA
09/2020 - 07/2009
4MicroRNAs (MicroRNA)IBA
01/2020 - 06/2009
4Aquaporins (Water Channels)IBA
01/2019 - 08/2010
4SuspensionsIBA
01/2019 - 08/2006
4Vascular Endothelial Growth Factor CIBA
01/2018 - 07/2009
4Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
10/2016 - 12/2004
4Tyrosine Kinase InhibitorsIBA
01/2016 - 04/2007
4Nerve Growth Factor (NGF)IBA
05/2014 - 08/2002
4FenretinideIBA
09/2013 - 07/2003
3ParaffinIBA
12/2022 - 10/2014
3Formaldehyde (Formol)FDA Link
12/2022 - 10/2014
3Phenobarbital (Luminal)FDA Link
01/2022 - 05/2011
3Cadherins (E-Cadherin)IBA
12/2021 - 12/2015
3InterleukinsIBA
09/2020 - 04/2005
3DystrophinIBA
10/2019 - 05/2003
3Chymases (Chymase)IBA
08/2019 - 08/2010
3Metalloproteases (Metalloproteinases)IBA
01/2019 - 12/2005
3Coloring Agents (Dyes)IBA
11/2018 - 08/2010
3Platelet-Derived Growth FactorIBA
08/2018 - 09/2008
3Angiopoietin-1IBA
08/2018 - 05/2009
3Transcription Factors (Transcription Factor)IBA
04/2018 - 09/2002
3NestinIBA
01/2018 - 01/2010
3Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
10/2017 - 04/2007
3Psychosine (Galactosylsphingosine)IBA
10/2015 - 09/2013

Therapy/Procedure

74Therapeutics
01/2024 - 02/2003
14Drug Therapy (Chemotherapy)
10/2022 - 11/2003
7Immunotherapy
04/2023 - 11/2008
4Radiotherapy
12/2015 - 09/2008